8 years ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
8 years ago Flutterby Fundraisers to Sponsor Consortium Scientist
8 years ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
9 years ago Gene Therapy Funding Update
9 years ago Consortium Student Live Facebook Interview from ASGCT
9 years ago
New Report on Multi Dose Clinical Trial Published
Thursday, July 21st 2016
A new in depth report on our MD clinical trial has been published by the National Institute for Health Research. The report is published in 'Efficacy and Mechanism Evaluation' a journal for studies funded by the NIHR via its EME programme.
The results of the clinical trial were originally published last summer (Alton et al., 2015) and this report contains no new data. However it represents a more extensive account of the clinical trial protocol and the raw data generated.
Chapters:-
- Introduction and background
- Methods: clinical trial design and outcome measures
- Results of clinical efficacy outcomes
- Results of mechanistic substudy
- Safety and adverse events
You can download a copy here.
Lentiviral Production in Wave Bioreactor (2015): Suspension cell culture is used to produce large quantities of Lentiviral vector. The rocking platform generates a 'wave' in the disposable bag which keeps cells in suspension. More...
